PeterO'HanleyMDPhD, MPH
Internal Medicine • Portland, ORHospital Medicine/Hospitalist, Infectious Disease
Clinical Professor
Dr. O'Hanley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3710 SW Jackson Park Road
Portland, OR 97239
Summary
- I am board certified in internal medicine working as a hospitalist. My primary professional career is focused in anti-infectives, interventional clinical trials.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Infectious Disease, 1981 - 1984
Providence Health & Services - Oregon/St Vincent Hospital and Medical CenterInternship, Internal Medicine, 1979 - 1980
Medical University of South CarolinaClass of 1979
Certifications & Licensure
CA State Medical License 2025 - 2027
FL State Medical License 2024 - 2026
NY State Medical License 2024 - 2026
OR State Medical License 1980 - 2025
WA State Medical License 2024 - 2025
ND State Medical License 2018 - 2019
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Study to Evaluate Efficacy and Safety of E-101 Solution for Preventing Surgical Site Infections After Colorectal Surgery Start of enrollment: 2013 Jan 10
Publications & Presentations
PubMed
- 1 citationsFive-Year Longitudinal Assessment (2008 to 2012) of E-101 Solution Activity against Clinical Target and Antimicrobial-Resistant PathogensGerald A. Denys, Chris M. Pillar, Daniel F. Sahm, Peter O'Hanley, Jackson T. Stephens
Antimicrobial Agents and Chemotherapy. 2014-08-01 - 3 citationsIn vitro and in vivo activities of E-101 solution against Acinetobacter baumannii isolates from U.S. military personnel.Gerald A. Denys, J. C. Davis, Peter O'Hanley, Jackson T. Stephens
Antimicrobial Agents and Chemotherapy. 2011-07-01 - 7 citationsIn vitro antibacterial activity of E-101 Solution, a novel myeloperoxidase-mediated antimicrobial, against Gram-positive and Gram-negative pathogensGerald A. Denys, Parveen Grover, Peter O'Hanley, Jackson T. Stephens
The Journal of Antimicrobial Chemotherapy. 2011-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
